medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 3

<< Back Next >>

Med Int Mex 2021; 37 (3)

COVID-19, Kawasaki disease and multisystem inflammatory syndrome: A conceptualization from the main reports

Polo-Martínez M, Montiel-Mejía J, Batista-Castellar V, Contreras-Puentes N, Conde-Cardona GC

Language: Spanish
References: 52
Page: 373-382
PDF size: 229.94 Kb.


ABSTRACT

Objective: To describe the clinical characteristics of patients with COVID-19 and an atypical variety of Kawasaki disease with systemic inflammatory processes in children, and their diagnostic and therapeutic procedures.
Methodology:Narrative literature review, from consultation of the databases of PubMed, Science Direct and Google academic. The following keywords (MeSH) were used for the search: “COVID-19”, “Kawasaki Disease”, “SARS-CoV-2”, “multisystem inflammatory syndrome”. Original articles and clinical case reports were included.
Results: Fifty-two articles were found, of which 27 were selected that met the inclusion criteria for analysis.
Conclusions: With the clinical manifestations associated with COVID-19 appeared atypical multisystemic inflammatory pictures and Kawasaki disease establishes an urgency of precise and prospective data of this syndrome that manages to differentiate, in its totality, Kawasaki disease or, in its absence, to define it as a variant of the same one. Physicians caring for patients with COVID-19 should be aware of the diagnostic criteria of the new syndrome and be vigilant, especially in countries with consistent case numbers where the majority of complicated patients may be seen following SARSCoV- 2 infection. In addition, these research updates imply an even deeper perspective for pathophysiological study, treatment indication and conceptualization of the clinical basis for its understanding.


REFERENCES

  1. WHO. Coronavirus disease (COVID-19) Situation Report -188. 2020; 1-16. https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports.

  2. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506. https://doi. org/10.1016/S0140-6736(20)30183-5.

  3. Guan WJ, Liang WH, Zhao Y, Liang HR, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J 2020; 55 (5): 2000547. doi. 10.1183/13993003.00547-2020.

  4. Jones VG, Mills M, Suarez D, Hogan CA, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr 2020; 10 (6): 537-40. https://doi.org/10.1542/ hpeds.2020-0123.

  5. Prego-Petit J. Enfermedad de Kawasaki. Arch Pediatr 2006; 7 (2): 70-83.

  6. Soni PR, Noval Rivas M, Arditi M. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Curr Rheumatol Rep 2020; 22 (2). https://doi.org/10.1007/ s11926-020-0882-1.

  7. Freeman AF, Shulman ST. Kawasaki disease: Summary of the American Heart Association guidelines. Am Fam Physician 2006; 74 (7): 1141-50. https://www.aafp.org/ afpsort.xml.

  8. Verdoni L, Mazza A, Gervasoni A, Martelli L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-8. http://dx.doi. org/10.1016/S0140-6736(20)31103-X.

  9. Holman RC, Belay ED, Christensen KY, Folkema AM, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29 (6): 483-8. doi. 10.1097/INF.0b013e3181cf8705.

  10. McCrindle BW, Rowley AH, Newburger JW, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017; 135: 927-99. https://doi.org/10.1161/ CIR.0000000000000484.

  11. Cogan E, Foulon P, Cappeliez O, Dolle N, et al. Multisystem inflammatory syndrome with complete Kawasaki disease features associated with SARS-CoV-2 infection in a young. Frontiers in Medicine 2020; 428. https://doi.org/10.3389/ fmed.2020.00428.

  12. Ouldali N, Pouletty M, Mariani P, Beyler C, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Heal 2020; 4 (9): 662-8. http://dx.doi.org/10.1016/S2352-4642(20)30175-9.

  13. Belot A, Antona D, Renolleau S, Javouhey E, et al. SARS-CoV- 2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 2020; 25 (22): 2001010.

  14. Belhadjer Z, Méot M, Bajolle F, Khraiche D, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020; 429-36. https://doi.org/10.1161/ CIRCULATIONAHA.120.048360.

  15. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395 (10237): 1607-8. http://dx.doi. org/10.1016/S0140-6736(20)31094-1.

  16. Davies P, Evans C, Kanthimathinathan HK, Lillie J, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet 2020; 4(20): 669-77. https:// doi.org/10.1016/S2352-4642(20)30215-7.

  17. Toubiana J. Outbreak of Kawasaki disease in children during COVID-19 pandemic a prospective observational study in Paris France. BMJ 2020;369:m2094. http://medrxiv.org/ cgi/content/short/2020.05.10.20097394.

  18. Ulloa-Gutiérrez R, Ivankovich-Escoto G, Yamazaki- Nakashimada MA. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes: un llamado al diagnóstico. Rev Chil Infectología 2020; 37 (3): 199-201. http://dx.doi.org/10.4067/s0716-10182020000300199.

  19. Loomba RS, Villarreal E, Flores S. Reply to the letter concerning Kawasaki Disease and Covid-19. Cardiol Young 2020;1- 2. http://www.ncbi.nlm.nih.gov/pubmed/32641195.

  20. Wiwanitkit V. Covid-19 and Kawasaki syndrome. Cardiol Young 2020; 30 (9): 1372. https://doi.org/10.1017/ S1047951120001894[Opens in a new window].

  21. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 2004; 158 (12): 1166-9. doi. 10.1001/archpedi.158.12.1166.

  22. Dergun M, Kao A, Hauger SB, Newburger JW, et al. Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med 2005; 159 (9): 876-81. doi. 10.1001/ archpedi.159.9.876.

  23. Lu X, Zhang L, Du H, Li YY, et al. SARS-CoV-2 Infection in Children To. N Engl J Med 2020; 382 (17): 1663-5. doi. 10.1056/NEJMc2005073.

  24. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020; 383 (4): 347-58. doi. 10.1056/ NEJMoa2021756.

  25. Koné-Paut I, Cimaz R. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD open. 2020; 6 (2): 1-4. http:// creativecommons.org/licenses/by-nc/4.0/.

  26. Licciardi F, Pruccoli G, Denina M, Parodi E, et al. SARS-CoV- 2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics 2020; 146 (2): e20201711. https://doi.org/10.1542/peds.2020- 1711.

  27. Pouletty M, Borocco C, Ouldali N, Caseris M, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort. Ann Rheum Dis. 2020; 79 (8): 999-1006. http://dx.doi.org/10.1136/annrheumdis- 2020-217960.

  28. Feldstein LR, Rose EB, Horwitz SM, Collins JP, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med 2020; 383 (4): 334-46. doi. 10.1056/NEJMoa2021680.

  29. Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, et al. Kawasaki Disease Features and Myocarditis in a Patient with COVID-19. Pediatr Cardiol 2020; 1-3. https://doi. org/10.1007/s00246-020-02393-0.

  30. Theocharis P, Wong J, Pushparajah K, Mathur SK, et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Hear J Cardiovascular Imaging 2020;jeaa212. doi. 10.1093/ehjci/jeaa212.

  31. Regev T, Antebi M. Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following sars-cov-2 infection. Pediatr Infect Dis J 2020; 39 (8): 206-7. doi. 10.1097/ INF.0000000000002804.

  32. Harahsheh AS, Dahdah N, Newburger JW, Portman MA, et al. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr 2020; 222: 261-2. https://doi.org/10.1016/j. jpeds.2020.04.052.

  33. Han CL, Zhao SL. Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Med Sci Monit. 2018; 24: 7264-70. doi. 10.12659/MSM.908678.

  34. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company’s public news and information. 2020.

  35. Grimaud M, Starck J, Levy M, Marais C, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 2020; 10 (1): 69. https://doi.org/10.1186/ s13613-020-00690-8.

  36. Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, et al. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series Eléonore. Radiology 2020: 202288. https://doi. org/10.1148/radiol.2020202288.

  37. Ramcharan T, Nolan O, Lai CY, Prabhu N, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020: 1-11. https:// doi.org/10.1007/s00246-020-02391-2.

  38. Toubiana J, Poirault C, Corsia A, Bajolle F, et al. Kawasakilike multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020; 369: m2094. https://doi. org/10.1136/bmj.m2094.

  39. Sokolovsky S, Soni P, Hoffman T, Kahn P, et al. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med. 2020;June 25: S0735-6757 (20): 30542-8. https://doi.org/10.1016/j.ajem.2020.06.053.

  40. Chérif MY, de Filette JMK, André S, Kamgang P, et al. Coronavirus disease 2019 -related Kawasaki-like disease in an adult: A case report. JAAD Case Reports 2020; 6 (8): 780- 782. https://doi.org/10.1016/j.jdcr.2020.06.023.

  41. Labé P, Ly A, Sin C, Nasser M, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatology Venereol 2020; 43 (10): e539-41. https://doi.org/10.1111/jdv.16666.

  42. Lidder AK, Pandit SA, Lazzaro DR. An adult with COVID-19 kawasaki-like syndrome and ocular manifestations. Am J Ophthalmol Case Reports 2020; 20: 100875. https://doi. org/10.1016/j.ajoc.2020.100875.

  43. Heidemann SM, Tilford B, Bauerfeld C, Martin A, et al. Three cases of pediatric multisystem inflammatory syndrome associated with COVID-19 due to SARS-CoV-2. Am J Case Rep 2020; 21: 1-5. 10.12659/AJCR.925779.

  44. Whittaker E, Bamford A, Kenny J, Kaforou M, et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA 2020; 324 (3): 259-69. doi.10.1001/ jama.2020.10369.

  45. Moraleda C, Serna-Pascual M, Soriano-Arandes A, Simó S, et al. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV- 2) in Spain. Clin Infect Dis 2020; ciaa1042: 1-5. https:// doi.org/10.1093/cid/ciaa1042.

  46. Cheung EW, Zachariah P, Gorelik M, Boneparth A, et al. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA - J Am Med Assoc 2020; 324 (3): 294-6. doi.10.1001/jama.2020.10374.

  47. Zhang M, Shi L, Li X, Lin Y, et al. Clinical Analysis of Kawasaki Disease Shock Syndrome Ming‑Ming. Chinese Med J 2017; 130 (6): 2891‑2.

  48. Ravelli A, Davì S, Minoia F, Martini A, et al. Macrophage Activation Syndrome. Hematol Oncol Clin North Am 2015; 29 (5): 927-41. https://doi.org/10.1016/j.hoc.2015.06.010.

  49. Yim D, Ramsay J, Kothari D, Burgner D. Coronary artery dilatation in toxic shock-like syndrome: The kawasaki disease shock syndrome. Pediatr Cardiol 2010; 31 (8): 1232-5. https://doi.org/10.1007/s00246-010-9771-0.

  50. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19 2020. https:// www.who.int/publications-detail/multisystem-inflammatorysyndrome- in-children-and-adolescents-with-covid-19.

  51. CDC. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID- 19). Emergency Preparedness and Response. 2020.

  52. Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases. Int J Infect Dis 2020; 97: 371-3. https://doi. org/10.1016/j.ijid.2020.06.014.




2020     |     www.medigraphic.com